#CRCTrialsChat (@crctrialschat) 's Twitter Profile
#CRCTrialsChat

@crctrialschat

Let's learn about CRC #Clinicaltrials
Patients, caregivers, clinicians, patient advocates: All are welcome!

Volunteer activity organized by @manjuggm

ID: 1525527871430729728

linkhttps://wakelet.com/@CRCTrialsChat257 calendar_today14-05-2022 17:26:38

4,4K Tweet

961 Followers

1,1K Following

Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

#ASCO2025 abstracts are out! So many great talks and studies. A few I'm really looking forward to: 1. ATOMIC. dMMR stage III CRC addition of Atezolizumab. Finally addressing checkpoint in the adjuvant setting? 2. MATTERHORN. GC/GEJC addition of Durva to FLOT. Its a plenary...

Christine Lovly, MD, PhD, FASCO (@christine_lovly) 's Twitter Profile Photo

Dr. Rakesh K. Jain honored with #AACR25 Lifetime Achievement in #CancerResearch for his pioneering contributions to understanding the TME. He shares that his first R01 was rejected 6 times. A great lesson in passion + persistence! Harvard University MassGeneral News AACR

Dr. Rakesh K. Jain honored with #AACR25 Lifetime Achievement in #CancerResearch for his pioneering contributions to understanding the TME. He shares that his first R01 was rejected 6 times. A great lesson in passion + persistence! <a href="/Harvard/">Harvard University</a> <a href="/MassGeneralNews/">MassGeneral News</a> <a href="/AACR/">AACR</a>
Jill Feldman (@jillfeldman4) 's Twitter Profile Photo

Opening plenary at #AACR25 Dr Pat LaRusso honors Dr Larry Salzman with the Distinguished Public Service Award. Thank you Dr Salzman for your fierce advocacy for medical research for life threatening diseases.

Opening plenary at #AACR25 Dr Pat LaRusso honors Dr Larry Salzman with the Distinguished Public Service Award. 
Thank you Dr Salzman for your fierce advocacy for medical research for life threatening diseases.
NEJM (@nejm) 's Twitter Profile Photo

Presented at #AACR25: Neoadjuvant PD-1 blockade with dostarlimab led to organ preservation in a high proportion of patients with early-stage mismatch repair–deficient tumors, with no compromise of surgical options. Full study results: nej.md/3EsWcoi  AACR

Presented at #AACR25:

Neoadjuvant PD-1 blockade with dostarlimab led to organ preservation in a high proportion of patients with early-stage mismatch repair–deficient tumors, with no compromise of surgical options. Full study results: nej.md/3EsWcoi  

<a href="/AACR/">AACR</a>
Jill Feldman (@jillfeldman4) 's Twitter Profile Photo

Dr Margaret Foti, PhD, MD (hc) presents Tammy Baldwin the #AACR25 Distinguished Public Service Award for her leadership in addressing the growing threats and consequences on patients, researchers, clinicians. Thank YOU Senator Baldwin!

M. Bolton (@5_utr) 's Twitter Profile Photo

I think so for colorectal and esophageal, considering also SANO trial, increasingly the question is can we hold off on surgery or reserve for salvage and that answer building “yes” evidence Dr. Nina Niu Sanford

Emil Lou, MD, PhD, FACP (@cancerassassin1) 's Twitter Profile Photo

Remote assessment of patients on clinical trial, via telemedicine, opens the door to more widespread enrollment from patients in rural areas and more. APOLLO trial in pancreatic cancer is the first NCI-funded trial to allow this -Shaalan Beg MD MBA FASCO #AACR25 Plenary

Allison Rosen, MS (@arosen380) 's Twitter Profile Photo

Great to hear from Shaalan Beg MD MBA FASCO at this mornings plenary at AACR discussing how to make clinical trials more accessible! One such tactic is decentralization of trials! They require retraining staff, educating patients & leveraging new technologies like AI #AACR25 #AACRSSP

Great to hear from <a href="/ShaalanBeg/">Shaalan Beg MD MBA FASCO</a> at this mornings plenary at <a href="/AACR/">AACR</a> discussing how to make clinical trials more accessible! One such tactic is decentralization of trials! They require retraining staff, educating patients &amp; leveraging new technologies like AI #AACR25 #AACRSSP
Allison Rosen, MS (@arosen380) 's Twitter Profile Photo

Alberto Bardelli discusses the exposome influences that contribute to early-onset disease. Innovative research in proteomics and molecular profiling will provide new insights into potential preventive, diagnostic and therapeutic strategies.AACR #AACR25 #AACRSSP #crcsm

Alberto Bardelli discusses the exposome influences that contribute to early-onset disease. Innovative research in proteomics and molecular profiling will provide new insights into potential preventive, diagnostic and therapeutic strategies.<a href="/AACR/">AACR</a> #AACR25 #AACRSSP #crcsm
patty spears (@paspears88) 's Twitter Profile Photo

Redefining Cancer Survivorship for People Living with Advanced and Metastatic Cancers. Great session with good practical information. Jill Feldman amazing as always … tells it as it is… #AACR25 #AACRSSP AACR

Redefining Cancer Survivorship for People Living with Advanced and Metastatic Cancers.  Great session with good practical information.  <a href="/jillfeldman4/">Jill Feldman</a> amazing as always … tells it as it is… #AACR25 #AACRSSP <a href="/AACR/">AACR</a>
Manju George MVSc PhD Rectal Cancer Survivor (@manjuggm) 's Twitter Profile Photo

I think the best part of #PatientAdvocacy for me is being able to interact with brilliant folks like these 2 fantastic women who are changing the world daily!! Thank you both for everything you do! Andrea Cercek Yin Cao #AACR2025 #CRCSM #EOCRC

I think the best part of #PatientAdvocacy for me is being able to interact with brilliant folks like these 2 fantastic women who are changing the world daily!! Thank you both for everything you do! <a href="/AndreaCercek/">Andrea Cercek</a> <a href="/yincaoScD/">Yin Cao</a> #AACR2025 #CRCSM #EOCRC
Oncology Brothers (@oncbrothers) 's Twitter Profile Photo

#ASCO25 is less than 4 weeks away! Honored to be among ASCO’s “Featured Voices,” representing general medical oncologists and our community. Follow these featured voices 👇👇 to stay updated on the latest in oncology!! #OncTwitter #MedTwitter #MedEd Roswell Park Wilmot Cancer Institute

#ASCO25 is less than 4 weeks away! Honored to be among <a href="/ASCO/">ASCO</a>’s “Featured Voices,” representing general medical oncologists and our community. Follow these featured voices 👇👇 to stay updated on the latest in oncology!!

#OncTwitter #MedTwitter #MedEd <a href="/RoswellPark/">Roswell Park</a> <a href="/WilmotCancer/">Wilmot Cancer Institute</a>
Smitha Krishnamurthi (@smitha42) 's Twitter Profile Photo

👀Adjuvant aspirin 160 mg for 3 years- now in NCCN for patients with PIK3CA mutated #ColorectalCancer 👉ALASCCA trial showed ⬇️ 3-year recurrence. 👉Results even more impressive in patients with PIK3R1 and PTEN mutant cancers (+DFS benefit) ❓How are oncologists obtaining this

Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

Congrats to Michael LaPelusa, MD for a great study adding to the avalanche of data showing neoadjuvant PDL1 for MSI-H rectal cancer is safe and effective! 3 year followup for pembrolizumab in MSI-H localized rectal cancer Strong use-case for ctDNA monitoring 3-year EFS 92% vs

Manju George MVSc PhD Rectal Cancer Survivor (@manjuggm) 's Twitter Profile Photo

It's been a month since we moved to MS! I started as an Asst Professor in the Dept of Population Science at the John D Bower School of Pop Health. Also working with UMMC Cancer Center and Research Institute to chair the MS #colorectalcancer Roundtable. To improving #CRC outcomes in MS! Rod Rocconi #CRCSM

It's been a month since we moved to MS! 
I started as an Asst Professor in the Dept of Population Science at the John D Bower School of Pop Health.
Also working with <a href="/UMMC_Cancer/">UMMC Cancer Center and Research Institute</a> to chair the MS #colorectalcancer Roundtable. 
To improving #CRC outcomes in MS! 
<a href="/rodrocconi/">Rod Rocconi</a> #CRCSM